High-performance liquid chromatographic analysis for the determination of a novel polymer-bound camptothecin derivative (MAG-camptothecin) and free camptothecin in human plasma
Ne. Schoemaker et al., High-performance liquid chromatographic analysis for the determination of a novel polymer-bound camptothecin derivative (MAG-camptothecin) and free camptothecin in human plasma, J CHROMAT B, 763(1-2), 2001, pp. 173-183
A selective HPLC assay is described for the determination of free and total
(free plus polymer-bound) camptothecin (CPT) in human plasma after adminis
tration of the anti-tumor drug MAG-CPT (polymer bound camptothecin). Total
CPT levels were determined after hydrolysis and free CPT was extracted from
acidified plasma using Oasis solid-phase extraction material. Extracts wer
e analyzed on a Zorbax SB-C-8 analytical column, using a mixture of acetoni
trile-25 mM phosphate buffer (pH 4.0) as the eluent. Detection was performe
d fluorimetrically. Concentrations of polymer-bound CPT were calculated by
subtraction of free from total CPT. The lower limits of quantitation of the
methods were 100 ng/ml for total and 1.0 ng/ml for free CPT using 50 mul a
nd 250 mul plasma, respectively. Special attention was paid to the stabilit
y of the analytes. The presented method was successfully applied in a clini
cal pharmacokinetic study in our institute. (C) 2001 Elsevier Science B.V.
All rights reserved.